Unknown PHASE3 INTERVENTIONAL 2-arm NCT01004900

Intraocular Pressure (IOP) Lowering Effect of Selective Laser Trabeculoplasty Versus Prostaglandin Analogues in Angle Closure Glaucoma

Comparison of Selective Laser Trabeculoplasty With Prostaglandin Analogues for Lowering Intraocular Pressure in Eyes With Primary Angle Closure Glaucoma

Sponsor: Singapore Eye Research Institute

Conditions Glaucoma

Interventions Selective Laser Trabeculoplasty Travoprost/ Timolol/ Azopt/ Brimonidine

Updated 5 times since 2017 Last updated: May 10, 2010 Started: Jun 30, 2009 Primary completion: Mar 31, 2011 Completion: Mar 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01004900, this PHASE3 trial focuses on Glaucoma and remains ongoing. Sponsored by Singapore Eye Research Institute, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Singapore Eye Research Institute

Data source: Singapore Eye Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Singapore, Singapore